A bill to amend the Federal Food, Drug, and Cosmetic Act, as amended, to prohibit the use of any name in connection with any prescription drug other than the official name designated for such drug by the Secretary of Health, Education, and Welfare.

referredUnited States· United States Congress· EN

Introduced

4 February 1977

Last action

—

Status

Referred to Senate Committee on Labor and Public Welfare (Subsequently: Human Resources).

Summary

Amends the Federal, Food, Drug and Cosmetic Act to require the Secretary of Health, Education, and Welfare to designate an official name for any prescription drugs within the preview of such Act. Deems such a prescription drug misbranded if its labeling or advertising bears any name other than such official name. Authorizes the Secretary to exempt such a prescription drug from this labeling and advertising requirement for up to one year in order to avoid confusion and permit the orderly transition of labeling and advertising names.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Introduced in Senate
summary · EN · 4 February 1977
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/95th-congress/senate-bill/642
Open data entity: https://api.congress.gov/v3/bill/95/s/642